Co-mutations of KRAS/BRAF and TP53 or the high tumor mutation burden to predict
- This topic has 0 replies, 1 voice, and was last updated 3 years, 11 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Co-mutations of KRAS/BRAF and TP53 or the high tumor mutation burden to predict survival in patients with biliary tract carcinoma.
https://meetinglibrary.asco.org/record/186587/abstract
Viewing 1 post (of 1 total)
- The forum ‘New Developments’ is closed to new topics and replies.